Key result
High visit-to-visit HbA1c variability linked to ~200% higher ISR risk in T2D patients.
Why the study?
Does high visit-to-visit HbA1c variability increase the risk of in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention?
Cohort (n=420)
No
Does high visit-to-visit HbA1c variability increase the risk of in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention?
High visit-to-visit HbA1c variability is an independent predictor of in-stent restenosis in patients with type 2 diabetes undergoing PCI, suggesting that glycemic stability is as important as absolute glycemic control.
Answers are grounded in this paper and cite their sources.
May warrant monitoring HbA1c variability post-PCI in T2D; leaves open whether targeting it reduces ISR.
BACKGROUND: variability is a potential predictor of ISR in diabetic patients after stent implantation. METHODS: variability for ISR. RESULTS: variability by SD or VIM yielded similar findings. CONCLUSIONS: variability is an independent predictor of incidence of ISR in patients with type 2 diabetes after stent implantation. Trial registration NCT02089360: NCT.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) conducted a cohort in Type 2 diabetes after percutaneous coronary intervention (n=420). High visit-to-visit HbA1c variability (highest tertile) vs. Low visit-to-visit HbA1c variability (lowest tertile) was evaluated on Incidence of in-stent restenosis (ISR) (HR 3.00, 95% CI 1.14-7.92, p=0.026). High visit-to-visit HbA1c variability was independently associated with an increased incidence of in-stent restenosis in patients with type 2 diabetes after stent implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: